Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Industry:
Biotechnology, Health Care, Science and Engineering
Investors Number:
1
Technology:
Geroscience
Last Funding Type:
Private Equity
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Founded Date:
1-1
Investor Type:
For Profit
Funding Status:
IPO
Total Funding:
$5M
Estimated Revenue:
$1M to $10M
Employee Number:
101-250